MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
2) Consolidators: Medical Device Sector
*Consolidators: Surgical Technology
Zimmer Biomet Holdings, Inc (NYSE: ZBH)*
Organization & Developments: Zimmer
Parents
Zimmer Biomet Holdings, Inc (NYSE: ZBH)*
Children
*patented minimally invasive surgical (MIS) techniques and technology
*SET (Surgical, Sports Medicine, Extremities and Trauma)
*Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.
*Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.
*ZIMMER ORTHOPEDICS MANUFACTURING LTD
*Zimmer: Business Areas
*Zimmer: New Products and Business Developments
*Zimmer: Organizations
*Zimmer's 2009 sales were approximately $4.1 billion.
2011: Zimmer, Benvenue Medical conclude distribution deal (2011)
2013: OrthoSensor links with Zimmer to sell knee replacement-balancing tech (2013)
2015: 9. Zimmer: 15.4% Profit Margin
2017: Can a New CEO Right the Ship Before Zimmer Sinks?
2017: U.S. Army_Zimmer_Notice of Intent for Sole Source Award for Spinal and Orthopedic Implants
2017: Zimmer Biomet: A Leading Medtech Player Facing Short-Term Issues - Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
2018: 65-- Zimmer Surgical Instrument and Screw Kits
2020: Zimmer Biomet: Secure Play For Orthopaedics Exposure, +20% Upside
2021: Zimmer Biomet bundles robotic surgery, apps and digital health programs into one orthopedics package
2022: Zimmer Biomet: Procedural Volumes Normalizing, Rate Buy_ seekingalpha.com
2022: Zimmer Biomet's Valuation Offset By Lackluster Growth And Limited Near-Term Margin Leverage_ seekingalpha.com
2023: Zimmer Biomet: Healthier Solutions Than Investment_seekingalpha.com
2023: Zimmer Biomet: Profit Growth Superb, Q1 Knee Growth, But Further Evidence Needed
2023: Zimmer Biomet: Still Many Questions After A Solid Year So Far_ seekingalpha.com
2024: Zimmer Biomet Still Not There Yet With Respect To Consistency And Share Recoveries
2024: Zimmer Biomet Stock: Don't Jump In At The 52-Week Low
2024: Zimmer Biomet: Brighter Prospects In H2 2024_ seekingalpha
2024: Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'_seekingalpha.com
2024: Zimmer Biomet's latest ASC play
2025: The biggest orthopedic device stories out of AAOS 2025
2025: Zimmer Biomet seeks to be ‘boldest medtech company on Earth’
2025: Zimmer Biomet: Adding To The Growth Profile
Jumps
*Key People: Zimmer
Finance & Acquisitions: Zimmer